NJ State Employees Deferred Compensation Plan’s BioTelemetry, Inc. BEAT Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,000	Closed	-$432K	–	521
2020 Q4	$432K	Hold	6,000	–	–	0.07%	294
2020 Q3	$273K	Hold	6,000	–	–	0.05%	349
2020 Q2	$271K	Hold	6,000	–	–	0.05%	346
2020 Q1	$231K	Hold	6,000	–	–	0.05%	351
2019 Q4	$278K	Hold	6,000	–	–	0.05%	420
2019 Q3	$244K	Hold	6,000	–	–	0.04%	440
2019 Q2	$289K	Hold	6,000	–	–	0.05%	433
2019 Q1	$376K	Hold	6,000	–	–	0.07%	361
2018 Q4	$358K	Sell	6,000 -2,000	-25%	-$120K	0.07%	323
2018 Q3	$516K	Sell	8,000 -2,000	-20%	-$112K	0.09%	303
2018 Q2	$450K	Sell	10,000 -2,000	-17%	-$79.8K	0.08%	337
2018 Q1	$373K	Buy	+12,000	New	+$395K	0.07%	374

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's BEAT Position: Q1 2021 in Review

NJ State Employees Deferred Compensation Plan sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,000 shares — an estimated $432K sold.

NJ State Employees Deferred Compensation Plan first reported a position in BEAT in Q1 2018 and held it in 12 quarters. The position peaked at $516K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

NJ State Employees Deferred Compensation Plan reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 6,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $432K.
NJ State Employees Deferred Compensation Plan first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 12 quarters.
NJ State Employees Deferred Compensation Plan's BioTelemetry, Inc. position peaked at $516K in Q3 2018.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2021, filed 26 Apr 2021.